Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Expression of vascular endothelial growth factor in oral squamous cell carcinoma

´ëÇѱ¸°­¾Ç¾È¸é¿Ü°úÇÐȸÁö 2015³â 41±Ç 1È£ p.11 ~ 18
±è¼®°ï, Park Seung-Goo, ±è°æ¿í,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼®°ï ( Kim Seok-Kon ) - Dankook University College of Medicine Department of Anesthesiology and Pain Medicine
 ( Park Seung-Goo ) - Dankook University College of Dentistry Department of Oral and Maxillofacial Surgery
±è°æ¿í ( Kim Kyung-Wook ) - Dankook University College of Dentistry Department of Oral and Maxillofacial Surgery

Abstract


Objectives: The goal of this study was to determine the correlation of clinicopathological factors and the up-regulation of vascular endothelial growth factor (VEGF) expression in oral squamous cell carcinoma.

Materials and Methods: Immunohistochemical staining of VEGF and quantitative real-time polymerase chain reaction (RT-PCR) of VEGF mRNA were performed in 20 specimens from 20 patients with oral squamous cell carcinoma and another 20 specimens from 20 patients with carcinoma in situ as a controlled group.

Results: The results were as follows: 1) In immunohistochemical study of poorly differentiated and invasive oral squamous cell carcinoma, high-level staining of VEGF was observed. Significantcorrelation was observed between immunohistochemical VEGF expression and histologic differentia-tion, tumor size of specimens (Pearson correlation analysis, significancer>0.6, P<0.05). 2) In VEGF quantitative RT-PCR analysis, progressive cancer showed more VEGF expression than carcinoma in situ. Paired-samples analysis determined the difference of VEGF mRNA expression level between cancer tissue and carcinoma in situ tissue, between T1 and T2-4 (Student¡¯s t-test, P<0.05).

Conclusion: These fndings suggest that up-regulation of VEGF may play a role in the angiogenesis and progression of oral squamous cell carcinoma.

Å°¿öµå

Squamous cell carcinoma; Vascular endothelial growth factor; Real-time polymerase chain reaction; Immunohistochemistry

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed